Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedMar 16, 2026
DataAggregated Company Financials
Companies49
  • 7D-1.9%
  • 3M-9.5%
  • 1Y-22.5%
  • YTD-12.2%

Over the last 7 days, the Medical Equipment industry has dropped 1.9%, driven by declines in Elekta and Getinge of 5.7% and 2.3%, respectively. The industry has fallen 22% in the last year. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 17 Mar 2026SEK 127.5bSEK 74.5bSEK 1.7b23.7x73.5x1.7x
Thu, 12 Feb 2026SEK 132.5bSEK 76.4bSEK 2.0b32x65.2x1.7x
Sat, 10 Jan 2026SEK 150.2bSEK 77.5bSEK 1.9b40.2x78x1.9x
Mon, 08 Dec 2025SEK 178.8bSEK 94.0bSEK 2.4b42.6x73.6x1.9x
Wed, 05 Nov 2025SEK 178.5bSEK 93.7bSEK 2.3b46.8x77.1x1.9x
Fri, 03 Oct 2025SEK 177.8bSEK 93.3bSEK 1.4b46.4x127.5x1.9x
Sun, 31 Aug 2025SEK 188.5bSEK 93.3bSEK 1.4b50.3x136.8x2x
Tue, 29 Jul 2025SEK 196.8bSEK 93.5bSEK 1.5b56x135.5x2.1x
Thu, 26 Jun 2025SEK 189.6bSEK 93.4bSEK 1.5b41.2x128x2x
Sat, 24 May 2025SEK 180.6bSEK 93.2bSEK 2.2b33.3x80.8x1.9x
Mon, 21 Apr 2025SEK 169.3bSEK 91.5bSEK 2.7b28.8x63.2x1.9x
Wed, 19 Mar 2025SEK 160.3bSEK 76.5bSEK 2.5b28.7x64.3x2.1x
Fri, 14 Feb 2025SEK 174.5bSEK 76.0bSEK 1.8b33.3x96.9x2.3x
Sun, 12 Jan 2025SEK 159.2bSEK 74.7bSEK 1.8b30.4x87.2x2.1x
Tue, 10 Dec 2024SEK 154.7bSEK 74.7bSEK 1.8b28x84.9x2.1x
Thu, 07 Nov 2024SEK 158.6bSEK 75.1bSEK 2.0b31x81.2x2.1x
Sat, 05 Oct 2024SEK 178.7bSEK 74.5bSEK 3.1b24.2x57.3x2.4x
Mon, 02 Sep 2024SEK 179.5bSEK 74.5bSEK 3.1b29.6x57.6x2.4x
Wed, 31 Jul 2024SEK 172.2bSEK 74.5bSEK 3.0b27.3x57.1x2.3x
Fri, 28 Jun 2024SEK 156.8bSEK 72.9bSEK 2.6b29.5x59.7x2.2x
Sun, 26 May 2024SEK 166.9bSEK 73.0bSEK 2.8b29.2x59.6x2.3x
Tue, 23 Apr 2024SEK 163.1bSEK 72.4bSEK 2.6b31.6x63.4x2.3x
Thu, 21 Mar 2024SEK 160.1bSEK 72.2bSEK 2.4b30.9x65.8x2.2x
Sat, 17 Feb 2024SEK 166.2bSEK 71.9bSEK 2.5b43x67.5x2.3x
Mon, 15 Jan 2024SEK 177.6bSEK 71.4bSEK 1.5b42.1x116.1x2.5x
Wed, 13 Dec 2023SEK 164.0bSEK 70.6bSEK 1.5b39.5x111.6x2.3x
Fri, 10 Nov 2023SEK 156.8bSEK 69.9bSEK 1.3b34.1x117.8x2.2x
Sun, 08 Oct 2023SEK 148.3bSEK 68.7bSEK 1.1b29.5x137x2.2x
Tue, 05 Sep 2023SEK 156.8bSEK 68.8bSEK 1.0b31x151.3x2.3x
Thu, 03 Aug 2023SEK 163.2bSEK 68.0bSEK 937.5m32.1x174.1x2.4x
Sat, 01 Jul 2023SEK 158.8bSEK 67.0bSEK 1.3b33.8x118x2.4x
Mon, 29 May 2023SEK 179.0bSEK 66.9bSEK 1.4b34.7x132.1x2.7x
Wed, 26 Apr 2023SEK 183.9bSEK 64.5bSEK 1.3b34.6x137.4x2.9x
Fri, 24 Mar 2023SEK 166.7bSEK 64.0bSEK 1.4b35.8x116.2x2.6x
Price to Earnings Ratio

116.2x


Total Market Cap: SEK 166.7bTotal Earnings: SEK 1.4bTotal Revenue: SEK 64.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 97.3x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 73.5x which is lower than its 3-year average PE of 97.3x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 6.5% per year over the last three years.
  • Revenues for these companies have grown 5.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.51%
Healthcare0.18%
Medical Equipment-1.86%
Medical Supplies2.22%
Medical Equipment-2.62%
Industry PE
  • Investors are most optimistic about the Medical Supplies industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 39.4%, which is higher than its past year's earnings decline of 8.1% per year.
  • Investors are most pessimistic about the Medical Equipment industry, which is trading close to its 3-year average of 79.3x.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 39% over the next 5 years.
  • This is better than its past earnings decline of 8.1% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VIMIAN Vimian GroupSEK 26.044.5%
+SEK 592.8m		-34.1%PE41x
XVIVO Xvivo PerfusionSEK 185.803.2%
+SEK 182.7m		-54.9%PE232.6x
STIL StilleSEK 194.007.5%
+SEK 121.3m		-21.5%PE31.3x
ACARIX AcarixSEK 0.3013.6%
+SEK 41.9m		9.7%PS47.5x
SCIB SciBase HoldingSEK 0.3015.6%
+SEK 41.9m		-27.9%PS7.7x

Latest News

SUS
SEK 32.00
Surgical Science Sweden
7D
1.8%
1Y
-75.4%

SUS: Organic Expansion Will Support Sector Leadership As Profitability Assumptions Are Refined

Analysts have trimmed their fair value estimate for Surgical Science Sweden from SEK 61 to SEK 57.6, reflecting tweaks to assumptions around the discount rate, revenue growth, profit margins and expected future P/E levels. Valuation Changes Fair Value: Reduced from SEK 61 to SEK 57.6, a trim of about 6% in the modelled estimate.
SCIB
SEK 0.30
SciBase Holding
7D
15.6%
1Y
-27.9%
GETI B
SEK 188.25
Getinge
7D
-2.7%
1Y
-15.7%

GETI B: Slightly Higher Dividend Will Still Leave P/E Looking Stretched

Analysts have kept their SEK 170.97 price target for Getinge broadly unchanged, citing only marginal tweaks to assumptions around the discount rate, revenue growth, profit margin and future P/E that do not materially alter their overall view of the shares. What's in the News Getinge AB has a proposed dividend of SEK 4.75 per share, compared with SEK 4.60 previously (Key Developments).
XVIVO
SEK 185.80
Xvivo Perfusion
7D
3.2%
1Y
-54.9%

XVIVO: Higher Growth Assumptions Will Support Continued Bullish Repricing

Analysts now set their price target for Xvivo Perfusion at SEK301.0, compared with the prior SEK316.6, reflecting updated assumptions around slightly higher revenue growth, a lower profit margin, a higher discount rate, and a modestly higher future P/E multiple. Valuation Changes Fair Value: SEK316.6 has been revised to SEK301.0, a modest reduction in the estimated valuation level.
SEZI
SEK 4.63
Senzime
7D
-3.5%
1Y
-16.4%
EKTA B
SEK 56.55
Elekta
7D
-5.0%
1Y
-1.7%
ARJO B
SEK 25.66
Arjo
7D
-0.8%
1Y
-33.0%

ARJO B: Future Returns Will Rely On Stable Margins And Required Yield

Analysts have kept their SEK 28.0 price target for Arjo unchanged, citing slightly updated assumptions for the discount rate, revenue growth, profit margin and future P/E as the basis for maintaining this level. Valuation Changes Fair Value: SEK 28 held steady, with the target level unchanged at SEK 28.0. Discount Rate: has risen slightly from 7.42% to 7.51%.
VIMIAN
SEK 26.04
Vimian Group
7D
4.5%
1Y
-34.1%

VIMIAN: Reduced Price Outlook And Execution Risks Will Shape Fairly Balanced Prospects

Analysts have lowered their price target on Vimian Group to SEK 25 from SEK 27, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. Analyst Commentary Bearish analysts have trimmed their fair value assumptions for Vimian Group, as seen in the reduced price target to SEK 25 from SEK 27.
OSSD
SEK 6.06
OssDsign
7D
4.7%
1Y
-51.3%

OSSD: New US Leadership Will Support Long Term Margin Expansion

Analysts have kept their OssDsign price target steady at SEK 12.75, citing largely unchanged assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E as the basis for maintaining their view. What's in the News OssDsign AB appointed Mark Waugh as CEO, effective January 1, 2026, following his senior roles at Smith & Nephew plc, Medtronic Sofamor Danek Inc, and Medacta USA (Key Developments).
PAX
SEK 45.80
Paxman
7D
-2.6%
1Y
-25.9%
IMP A SDB
SEK 40.40
Implantica
7D
-1.7%
1Y
26.3%
SEDANA
SEK 9.29
Sedana Medical
7D
3.2%
1Y
-41.9%
STIL
SEK 194.00
Stille
7D
7.5%
1Y
-21.5%

Stille AB Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 15
Stille AB Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
ACARIX
SEK 0.30
Acarix
7D
13.6%
1Y
9.7%
QLINEA
SEK 21.95
Q-linea
7D
-5.6%
1Y
-46.2%

We Think Q-linea (STO:QLINEA) Needs To Drive Business Growth Carefully

Feb 10
We Think Q-linea (STO:QLINEA) Needs To Drive Business Growth Carefully
CEVI
SEK 150.20
CellaVision
7D
-2.7%
1Y
-12.3%